Document is current
Any future updates will be listed below
-
Authors
Gong, Aobo
Cao, Ying
Li, Zexi
Li, Wentao
Li, Fanghui
Tong, Yao
Hu, Xianjin
Zeng, Rui
-
Funding
Funding for this research was provided by:
1•3•5 Project for Disciplines of Excellence-Clinical Research Incubation Project (No. 2023HXFH002)
Sichuan Science and Technology Program (2022YFS0279)
Sichuan Provincial Health Commission (Chuanganyan ZH2022-101)
Sichuan University West China Nursing Discipline Development Special Fund Project (HXHL20017)
- License Information
-
More Information
Article History
Received: 7 May 2024
Accepted: 20 January 2025
First Online: 25 January 2025
Declarations
:
: This study was approved by the West China Hospital of Sichuan University Biomedical Research Ethics Committee (No. 2022 − 306). Written informed consent was obtained from all participants, and the data were anonymized before analysis.
: Not applicable.
: The authors declare no competing interests.
: Supplementary Material 1: Additional file 1: Univariate cox regression for all variables. HR: hazard ratio; AF: atrial fibrillation; CHA2DS2-VASc: Heart failure, hypertension, diabetes, coronary artery disease/peripheral artery disease and female with one point each, one point for 65–74 years old, and two points for ≥ 75 years old, stroke/transient ischemic attack/systemic embolism with 2 points; TIA: transient ischemic attack; COPD: chronic obstructive pulmonary disease; GGT: glutamyl transpeptidase; LDL: low density lipoprotein; HDL: high density lipoprotein; SUA: serum uric acid; SCR: serum creatinine; NT-pro BNP: N-terminal pro B-type natriuretic peptide; LAD: left atrial anterior-posterior diameter; LVD: left ventricular maximum diameter; RAD: right atrial maximum diameter; RVD: right ventricular maximum diameter; LVEF: left ventricular ejection fraction; OAC: oral anticoagulation; ARNI: Angiotensin Receptor & Neprilysin Inhibitor; ACEI: angiotensin converting enzyme inhibitor; ARB: angiotensin receptor blocker; Tyg: triglyceride glucose index.Supplementary Material 2: Additional file 2: Multivariate cox regression model for Tyg index (as categorical data) adjusting for CHA2DS2-VASc variables and catheter ablation. TIA: transient ischemic attack; CAD: coronary artery disease; PAD: peripheral artery disease; Tyg: triglyceride glucose index; HR: hazard ratios.Supplementary Material 3: Additional file 3: Multivariate cox regression model for Tyg index (as continuous data) adjusting for CHA2DS2-VASc variables and catheter ablation. TIA: transient ischemic attack; CAD: coronary artery disease; PAD: peripheral artery disease; Tyg: triglyceride glucose index; HR: hazard ratio.Supplementary Material 4: Additional file 4: Forest plot for subgroup analysis. AF = atrial fibrillation.Supplementary Material 5: Additional file 5: Editing certificate.Supplementary Material 6: Additional file 6: Similarity check report.
